On September 22, 2023 AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company") reported Chris McAleer, Ph.D., Scientific Officer of AIM will present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care being held at the Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., September 20-22, 2023 (Press release, AIM ImmunoTech, SEP 22, 2023, View Source [SID1234635341]). In addition to the presentation, the Company is proud to announce its sponsorship of the event.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details for the presentation are as follows:
Title: Rintatolimod (Ampligen): Overview of Ampligen’s Clinical Progress in Oncology
Presenter: Christopher McAleer, Ph.D.
Session: Session 7: Team Science: National and International Collaborations with NGOs, Academia, Pharma, & Biotech
Date: Friday, September 22, 2023
For more information about the conference, visit: View Source
The presentation will be available on the AIM website once presented at the conference.